RUNX2 and cleidocranial dysplasia 1: To explore the effects of mutations in the RUNT domain of RUNX2, here, we examined the cellular impact of the RUNX2 mutation c.505C > T in induced mesenchymal stem cells (iMSCs) obtained from induced pluripotent stem cells derived from one 26-year-old female CCD patient (Fig. S1).